2022 hasn’t been kind to rate-sensitive growth stocks, as the prospect of tighter monetary policy has dampened the risk-on mood across Wall Street. Luckily, income investors have long placed strong emphasis on defensive plays. Health care and pharma stocks involved in cancer treatment and vaccinations fit that description – and pay good dividends to boot. You can now review this opportunity with our latest Best Health Care Dividend Stocks List pick.
Thanks to increased manufacturing capacity, the successful launch of oral antiviral medication for COVID-19 and a renewed focus on animal health, our big pharma pick is on track to continue delivering shareholder value. Our pick yields an impressive 3.2% dividend and is set to reap the benefits of strategic investments in manufacturing as it seeks to double the production of its leading human papillomavirus (HPV) vaccine by 2023.
While our pick has been around since 1891, it only showed up on income investors’ radar after the 2008-09 financial crisis. It has maintained a positive dividend growth policy for 10+ consecutive years. Watch out for the stock when it goes ex-dividend on Thursday, June 23 (estimated date).
You can check out the Best Health Care Dividend Stocks List to explore all the stocks.
